Glycine toxicity after high-dose i.v. infusion of 1.5% glycine in the mouse

被引:28
|
作者
Olsson, J
Hahn, RG
机构
[1] Cent Hosp, Dept Anaesthesia & Intens Care, Sundsvallt, Sweden
[2] Soder Hosp, Karolinska Inst, Stockholm, Sweden
关键词
toxicity; glycine; pharmacology; monitoring; electrocardiography; complications; hyponatraemia; mouse;
D O I
10.1093/bja/82.2.250
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Glycine 1.5% is the most widely used irrigating fluid during endoscopic procedures. To investigate if glycine toxicity is a mechanism promoting a fatal outcome when the solution is absorbed, we administered glycine 200 or 300 ml kg(-1) dissolved in sterile water or normal saline, and also normal saline alone, over 60 min by i.v. infusion to 100 mice under methoxyflurane anaesthesia. Survival rates were 29% after 1.5% glycine, 21% after 1.5% glycine in normal saline, 67% after normal saline and 100% in controls. Both solutions containing glycine induced bradycardia and prolongation of the PQ interval and QRS duration, while only 1.5% glycine increased the water content of the myocardium. These results suggest that glycine promotes bradycardia and death, regardless of whether hyponatraemia or hypo-osmolality is present. We conclude that glycine toxicity is an important factor that increases the risk of administration of an irrigating fluid.
引用
收藏
页码:250 / 254
页数:5
相关论文
共 50 条
  • [41] A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours
    Sastre, J
    Paz-Ares, L
    Carcas, A
    Alfonso, R
    Grávalos, C
    Frias, J
    Guerra, P
    Pronk, L
    Cortes-Funes, H
    Diaz-Rubio, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (05) : 453 - 460
  • [42] Transcriptional response in normal mouse tissues after i.v. 211At administration - response related to absorbed dose, dose rate, and time
    Langen, Britta
    Rudqvist, Nils
    Parris, Toshima Z.
    Schuler, Emil
    Spetz, Johan
    Helou, Khalil
    Forssell-Aronsson, Eva
    EJNMMI RESEARCH, 2015, 5 : 1 - 12
  • [43] A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours
    Javier Sastre
    Luis Paz-Ares
    Antonio Carcas
    Rosario Alfonso
    Cristina Grávalos
    Jesus Frías
    Pedro Guerra
    Linda Pronk
    Hernán Cortés-Funes
    Eduardo Díaz-Rubio
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 453 - 460
  • [44] EARLY PULMONARY TOXICITY AFTER ADMINISTRATION OF HIGH-DOSE BCNU
    LITAM, JP
    DAIL, DH
    SPITZER, G
    VELLEKOOP, L
    VERMA, DS
    ZANDER, AR
    DICKE, KA
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 39 - 44
  • [45] MANAGEMENT OF ACUTE TOXICITY AFTER HIGH-DOSE METHOTREXATE THERAPY
    URBAN, C
    MUTZ, I
    KOTZ, R
    KRISCH, K
    ONKOLOGIE, 1979, 2 (06): : 238 - 242
  • [46] PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE AFTER SHORT-TERM INFUSION
    KOHL, P
    KOPPLER, H
    SCHMIDT, L
    FRITSCH, HW
    HOLZ, J
    PFLUGER, KH
    JUNGCLAS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (04) : 316 - 320
  • [47] Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
    Naumovska, Magdalena
    Sheikh, Rafi
    Bengtsson, Boel
    Malmsjo, Malin
    Hammar, Bjorn
    BMC NEUROLOGY, 2018, 18
  • [48] CONTINUOUS VINCRISTINE INFUSION AS PART OF A HIGH-DOSE CHEMORADIOTHERAPY REGIMEN - DRUG KINETICS AND TOXICITY
    PINKERTON, CR
    MCDERMOTT, B
    PHILIP, T
    BIRON, P
    ARDIET, C
    VANDENBERG, H
    BRUNATMENTIGNY, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (03) : 271 - 274
  • [49] Visual outcome is similar in optic neuritis patients treated with oral and i.v. high-dose methylprednisolone: a retrospective study on 56 patients
    Magdalena Naumovska
    Rafi Sheikh
    Boel Bengtsson
    Malin Malmsjö
    Björn Hammar
    BMC Neurology, 18
  • [50] Case of bullous pemphigoid who achieved a long-term remission by a single course of high-dose i.v. immunoglobulin monotherapy
    Yu, Yue
    Furuta, Junichi
    Watanabe, Rei
    Inoue, Sae
    Nakamura, Yoshiyuki
    Ishitsuka, Yosuke
    Okiyama, Naoko
    Ishii, Yoshiyuki
    Fujisawa, Yasuhiro
    JOURNAL OF DERMATOLOGY, 2020, 47 (06): : E225 - E227